View Systems (VSYM) Reports Medical Therapeutics Has Profitable Quarter

Baltimore, MD - (NewMediaWire) - June 14, 2018 - View Systems (OTC: VSYM).,  Medical Therapeutics, a concierge medical service providing aging and sexual health therapies has reported a profitable quarter. The Erectile Dysfunction (ED) industry is projected to reach $7.64 billion in 2019.  Medical Therapeutics has been taking steps to capitalize on this growth market.

William Kelly, Director of Operations, states, "Last December we hired three additional staff members which have generated sufficient revenue to cash flow the Baltimore clinic into profitability.  We have partnered with two of the largest patient financing companies to offer all of our patients credit options, regardless of their credit history. We are building monthly residual reorders which maintain our cash flow.  We are opening additional clinics in Pittsburgh this summer as well as another in Chicago, IL in early autumn.  We guarantee positive results for our patients or do not charge for their visit”

The demographics of the industry indicate there are 50 million men over the age of 50 who are experiencing health issues resulting in erectile dysfunction due to a variety of maladies such as: diabetes, high blood pressure, prostate difficulties, side effects of prescription drugs, testosterone decline and cardiovascular issues. 

Medical Therapeutics is poised to continue capturing a share of the Baltimore/Washington and Pittsburgh metropolitan areas but will be focusing on franchise and other opportunities.

About View Systems/Medical Therapeutics:

View Systems’s subsidiary Medical Therapeutics is entering new and additional markets to include boutique medical clinics offering a variety of specialized procedures to appropriate patient demographics. View Systems Inc. continues to provide security and surveillance products to law enforcement facilities such as correctional institutions as well as to government agencies, schools, courthouses, event and sports venues, the military, and commercial businesses.

Safe Harbor Statement:

This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

Medical Therapeutics,